EGFR and metastatic colorectal cancer: This study was conducted to investigate the effects of AREG on cetuximab response in patients with metastatic colorectal cancer and determine the mode of action via the EGFR signaling pathway using in vitro experiments with both cetuximab-naïve and resistant colorectal cancer cell lines.